Previous close | 381.95 |
Open | 379.63 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 500.00 |
Expiry date | 2024-10-18 |
Day's range | 379.63 - 382.02 |
Contract range | N/A |
Volume | |
Open interest | N/A |
PFE obtains $1 billion from activist investor Starboard Value. Stock gains on hopes of a plausible turnaround of the struggling pharma giant.
Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer have been highlighted in this Industry Outlook article.
Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), AstraZeneca (AZN), Pfizer (PFE), Sanofi (SNY) and Bayer (BAYRY) are worth retaining in one's portfolio.